Condition: Cardiogenic Shock · Sponsor: CMC Ambroise Paré
Cardiogenic shock is a life-threatening condition characterized by inadequate cardiac output, leading to organ hypoperfusion and high mortality. Maintaining mean arterial pressure (MAP) is crucial, but standard targets may be insufficient due to venous congestion. Central venous pressure (CVP) can help assess effective perfusion pressure. This study investigates whether a personalized MAP target adjusted by CVP improves organ function and survival compared to standard MAP management.
This description comes directly from the study's public registry record.
Armand MEKONTSO DESSAP, MD · + 33 1 45 17 85 06 · armand.dessap@aphp.fr
Always discuss trial participation with your own doctor first.
| CHU d'Amiens-Picardie | Amiens, France | Not Yet Recruiting |
| Hôpital Henri Mondor | Créteil, France | Not Yet Recruiting |
| Hôpital Privé Jacques Cartier | Massy, France | Not Yet Recruiting |
| CMC Ambroise Paré - Hartmann | Neuilly-sur-Seine, France | Recruiting |
| CHU d'Orléans | Orléans, France | Not Yet Recruiting |
| Hôpital Lariboisière | Paris, France | Not Yet Recruiting |
| Hôpital Cochin | Paris, France | Not Yet Recruiting |
| Clinique NCT + /Saint-Gatien | Saint-Cyr-sur-Loire, France | Not Yet Recruiting |
| Centre Cardiologique du Nord | Saint-Denis, France | Not Yet Recruiting |
| CHRU de Strasbourg | Strasbourg, France | Not Yet Recruiting |
| CHU de Toulouse | Toulouse, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07345559